PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (1998) 22: 671-674. doi: 10.1192/pb.22.11.671
© 1998 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, J. M.
Right arrow Articles by Wright, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Barber, J. M.
Right arrow Articles by Wright, M.

Monitoring patients on high-dose antipsychotics

Joan M. Barber, Senior Registrar

Department of Psychiatry, Southern General Hospital, Glasgow

Jennifer Connaughton, Consultant Psychiatrist* and Morag Wright, Pharmacist

The State Hospital, Carstairs, Lanark, Scotland ML11 8RP

* Correspondence

Aims and method Following the publication of the 1994 Consensus Statement on the use of high-dose antipsychotic medication, we identified our high-dose patients and undertook an audit of the recommended physical investigations. The patients were identified by scrutiny of prescription records. Data were collected retrospectively at six-monthly intervals for four audit cycles. Results were fed back to clinicians at the hospital journal club.

Results The percentage of patients identified in the high-dose category fell from 35 to 23% over 18 months. Electrocardiograph monitoring of the group increased from 5 to 63%. Other tests showed a similar improvement. A very small number of abnormal results was shown. There were no untoward cardiac events.

Clinical implications Introduction of the standards of physical monitoring advised in the Consensus Statement has implications of cost to the NHS to be balanced against risk avoidance for patients. The number of abnormalities detected in our population was low. Changing prescribing behaviour in response to reported abnormal findings proved unexpectedly slow and a new systemwas required.




This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
L. D. G. Thomson
Management of schizophrenia in conditions of high security
Advan. Psychiatr. Treat., July 1, 2000; 6(4): 252 - 260.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1998 The Royal College of Psychiatrists.